Provided by Tiger Trade Technology Pte. Ltd.

Jasper Therapeutics

0.5600
-0.0097-1.70%
Volume:362.71K
Turnover:202.82K
Market Cap:18.63M
PE:-0.60
High:0.5800
Open:0.5626
Low:0.5403
Close:0.5697
52wk High:2.69
52wk Low:0.3151
Shares:33.27M
Float Shares:30.00M
Volume Ratio:1.13
T/O Rate:1.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9300
EPS(LYR):-3.9545
ROE:-255.05%
ROA:-113.41%
PB:13.19
PE(LYR):-0.14

Loading ...

Oct 01, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 29, 2021

Major Issues Report

8-K - Current report
Sep 29, 2021

Major Issues Report

8-K/A [Amend] - Current report
Sep 27, 2021

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Sep 23, 2021

Major Issues Report

8-K - Current report
Sep 20, 2021

Major Issues Report

8-K - Current report
Sep 20, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Sep 17, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Sep 09, 2021

Major Issues Report

8-K - Current report
Sep 09, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Sep 08, 2021

Business Combinations

425 - Prospectuses and communications, business combinations
Aug 24, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 20, 2021

Correspondence

CORRESP [Cover] - Correspondence
Aug 16, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 23, 2021

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]
Jul 22, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 21, 2021

Correspondence

CORRESP [Cover] - Correspondence
Jul 19, 2021

[Rev.]Annual Report

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
Jul 19, 2021

[Rev.]Quaterly Report

10-Q/A [Amend] - Quarterly report [Sections 13 or 15(d)]